文献
J-GLOBAL ID:202002240644343568
整理番号:20A2199950
活動性潰瘍性大腸炎患者の無作為化試験におけるホスホジエステラーゼ4の経口阻害剤,アプレミラストの効果【JST・京大機械翻訳】
Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative Colitis
著者 (12件):
Danese Silvio
(Humanitas Clinical and Research Center - IRCCS, Milan, Italy)
,
Danese Silvio
(Humanitas University, Department of Biomedical Sciences, Milan, Italy)
,
Neurath Markus F.
(Department of Internal Medicine, Friedrich-Alexander-Universitaet Erlangen-Nuernberg, Erlangen, Germany)
,
Kopon Adam
(Department of Gastroenterology, Torunskie Centrum Gastrologiczne Gastromed, Torun, Poland)
,
Zakko Salam F.
(Connecticut Clinical Research Institute, Bristol Hospital, Bristol, Connecticut)
,
Simmons Timothy C.
(West Gastroenterology Medical Group, Los Angeles, California)
,
Fogel Ronald
(Clinical Research Institute of Michigan, Digestive Health Center of Michigan, Chesterfield, Michigan)
,
Siegel Corey A.
(Department of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire)
,
Panaccione Remo
(Inflammatory Bowel Disease Clinic, University of Calgary, Calgary, Alberta, Canada)
,
Zhan Xiaojiang
(Clinical Research, Celgene Corporation, Summit, New Jersey)
,
Usiskin Keith
(Clinical Research, Celgene Corporation, Summit, New Jersey)
,
Chitkara Denesh
(Clinical Research, Celgene Corporation, Summit, New Jersey)
資料名:
Clinical Gastroenterology and Hepatology
(Clinical Gastroenterology and Hepatology)
巻:
18
号:
11
ページ:
2526-2534.e9
発行年:
2020年
JST資料番号:
W3126A
ISSN:
1542-3565
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)